## **Core Concept**
Non-immune hemolytic anemia refers to the premature destruction of red blood cells (RBCs) not caused by an immune response. This type of hemolysis can result from various factors, including mechanical damage, infections, drugs, and inherited or acquired disorders affecting the RBC membrane or metabolism.

## **Why the Correct Answer is Right**
Option describes a condition known as Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. G6PD deficiency is a genetic disorder that affects the enzyme glucose-6-phosphate dehydrogenase, crucial for maintaining the integrity of RBCs by protecting them from oxidative stress. A deficiency in this enzyme makes RBCs more susceptible to hemolysis under certain conditions, such as exposure to specific drugs or infections. This condition leads to non-immune hemolytic anemia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to a well-known cause of non-immune hemolytic anemia.
- **Option B:** This option is incorrect as it does not specify a condition directly associated with non-immune hemolytic anemia.
- **Option C:** This option might seem plausible but does not directly relate to a commonly recognized cause of non-immune hemolytic anemia.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that G6PD deficiency is a common cause of non-immune hemolytic anemia, particularly in individuals of Mediterranean, African, or Asian descent. Patients with G6PD deficiency may experience acute hemolytic anemia triggered by certain medications (e.g., primaquine, sulfonamides) or infections.

## **Correct Answer:** . G6PD deficiency